CACNA1A variants may modify the epileptic phenotype of Dravet syndrome

Iori Ohmori, Mamoru Oouchida, Katsuhiro Kobayashi, Yoshimi Jitsumori, Akiko Mori, Hiroyuki Michiue, Tei-ichi Nishiki, Yoko Ohtsuka, Hideki Matsui

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Dravet syndrome is an intractable epileptic syndrome beginning in the first year of life. De novo mutations of SCN1A, which encode the Nav1.1 neuronal voltage-gated sodium channel, are considered the major cause of Dravet syndrome. In this study, we investigated genetic modifiers of this syndrome.We performed a mutational analysis of all coding exons of CACNA1A in 48 subjects with Dravet syndrome. To assess the effects of CACNA1A variants on the epileptic phenotypes of Dravet syndrome, we compared clinical features in two genotype groups: 1) subjects harboring SCN1A mutations but no CACNA1A variants (n=20) and 2) subjects with SCN1A mutations plus CACNA1A variants (n=20). CACNA1A variants detected in patients were studied using heterologous expression of recombinant human Cav2.1 in HEK 293 cells and whole-cell patch-clamp recording.Nine CACNA1A variants, including six novel ones, were detected in 21 of the 48 subjects (43.8%). Based on the incidence of variants in healthy controls, most of the variants seemed to be common polymorphisms. However, the subjects harboring SCN1A mutations and CACNA1A variants had absence seizures more frequently than the patients with only SCN1A mutations (8/20 vs. 0/20, p=0.002). Moreover, the former group of subjects exhibited earlier onset of seizures and more frequent prolonged seizures before one year of age, compared to the latter group of subjects. The electrophysiological properties of four of the five novel Cav2.1 variants exhibited biophysical changes consistent with gain-of-function. We conclude that CACNA1A variants in some persons with Dravet syndrome may modify the epileptic phenotypes.

Original languageEnglish
Pages (from-to)209-217
Number of pages9
JournalNeurobiology of Disease
Volume50
Issue number1
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Myoclonic Epilepsy
Phenotype
Mutation
NAV1.1 Voltage-Gated Sodium Channel
Seizures
Absence Epilepsy
HEK293 Cells
Exons
Genotype
Incidence

Keywords

  • CACNA1A
  • Electrophysiology
  • Epilepsy
  • Molecular genetics
  • SCN1A

ASJC Scopus subject areas

  • Neurology

Cite this

CACNA1A variants may modify the epileptic phenotype of Dravet syndrome. / Ohmori, Iori; Oouchida, Mamoru; Kobayashi, Katsuhiro; Jitsumori, Yoshimi; Mori, Akiko; Michiue, Hiroyuki; Nishiki, Tei-ichi; Ohtsuka, Yoko; Matsui, Hideki.

In: Neurobiology of Disease, Vol. 50, No. 1, 02.2013, p. 209-217.

Research output: Contribution to journalArticle

Ohmori, Iori ; Oouchida, Mamoru ; Kobayashi, Katsuhiro ; Jitsumori, Yoshimi ; Mori, Akiko ; Michiue, Hiroyuki ; Nishiki, Tei-ichi ; Ohtsuka, Yoko ; Matsui, Hideki. / CACNA1A variants may modify the epileptic phenotype of Dravet syndrome. In: Neurobiology of Disease. 2013 ; Vol. 50, No. 1. pp. 209-217.
@article{7102a9ff8be74c848446d341cbbf98cc,
title = "CACNA1A variants may modify the epileptic phenotype of Dravet syndrome",
abstract = "Dravet syndrome is an intractable epileptic syndrome beginning in the first year of life. De novo mutations of SCN1A, which encode the Nav1.1 neuronal voltage-gated sodium channel, are considered the major cause of Dravet syndrome. In this study, we investigated genetic modifiers of this syndrome.We performed a mutational analysis of all coding exons of CACNA1A in 48 subjects with Dravet syndrome. To assess the effects of CACNA1A variants on the epileptic phenotypes of Dravet syndrome, we compared clinical features in two genotype groups: 1) subjects harboring SCN1A mutations but no CACNA1A variants (n=20) and 2) subjects with SCN1A mutations plus CACNA1A variants (n=20). CACNA1A variants detected in patients were studied using heterologous expression of recombinant human Cav2.1 in HEK 293 cells and whole-cell patch-clamp recording.Nine CACNA1A variants, including six novel ones, were detected in 21 of the 48 subjects (43.8{\%}). Based on the incidence of variants in healthy controls, most of the variants seemed to be common polymorphisms. However, the subjects harboring SCN1A mutations and CACNA1A variants had absence seizures more frequently than the patients with only SCN1A mutations (8/20 vs. 0/20, p=0.002). Moreover, the former group of subjects exhibited earlier onset of seizures and more frequent prolonged seizures before one year of age, compared to the latter group of subjects. The electrophysiological properties of four of the five novel Cav2.1 variants exhibited biophysical changes consistent with gain-of-function. We conclude that CACNA1A variants in some persons with Dravet syndrome may modify the epileptic phenotypes.",
keywords = "CACNA1A, Electrophysiology, Epilepsy, Molecular genetics, SCN1A",
author = "Iori Ohmori and Mamoru Oouchida and Katsuhiro Kobayashi and Yoshimi Jitsumori and Akiko Mori and Hiroyuki Michiue and Tei-ichi Nishiki and Yoko Ohtsuka and Hideki Matsui",
year = "2013",
month = "2",
doi = "10.1016/j.nbd.2012.10.016",
language = "English",
volume = "50",
pages = "209--217",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - CACNA1A variants may modify the epileptic phenotype of Dravet syndrome

AU - Ohmori, Iori

AU - Oouchida, Mamoru

AU - Kobayashi, Katsuhiro

AU - Jitsumori, Yoshimi

AU - Mori, Akiko

AU - Michiue, Hiroyuki

AU - Nishiki, Tei-ichi

AU - Ohtsuka, Yoko

AU - Matsui, Hideki

PY - 2013/2

Y1 - 2013/2

N2 - Dravet syndrome is an intractable epileptic syndrome beginning in the first year of life. De novo mutations of SCN1A, which encode the Nav1.1 neuronal voltage-gated sodium channel, are considered the major cause of Dravet syndrome. In this study, we investigated genetic modifiers of this syndrome.We performed a mutational analysis of all coding exons of CACNA1A in 48 subjects with Dravet syndrome. To assess the effects of CACNA1A variants on the epileptic phenotypes of Dravet syndrome, we compared clinical features in two genotype groups: 1) subjects harboring SCN1A mutations but no CACNA1A variants (n=20) and 2) subjects with SCN1A mutations plus CACNA1A variants (n=20). CACNA1A variants detected in patients were studied using heterologous expression of recombinant human Cav2.1 in HEK 293 cells and whole-cell patch-clamp recording.Nine CACNA1A variants, including six novel ones, were detected in 21 of the 48 subjects (43.8%). Based on the incidence of variants in healthy controls, most of the variants seemed to be common polymorphisms. However, the subjects harboring SCN1A mutations and CACNA1A variants had absence seizures more frequently than the patients with only SCN1A mutations (8/20 vs. 0/20, p=0.002). Moreover, the former group of subjects exhibited earlier onset of seizures and more frequent prolonged seizures before one year of age, compared to the latter group of subjects. The electrophysiological properties of four of the five novel Cav2.1 variants exhibited biophysical changes consistent with gain-of-function. We conclude that CACNA1A variants in some persons with Dravet syndrome may modify the epileptic phenotypes.

AB - Dravet syndrome is an intractable epileptic syndrome beginning in the first year of life. De novo mutations of SCN1A, which encode the Nav1.1 neuronal voltage-gated sodium channel, are considered the major cause of Dravet syndrome. In this study, we investigated genetic modifiers of this syndrome.We performed a mutational analysis of all coding exons of CACNA1A in 48 subjects with Dravet syndrome. To assess the effects of CACNA1A variants on the epileptic phenotypes of Dravet syndrome, we compared clinical features in two genotype groups: 1) subjects harboring SCN1A mutations but no CACNA1A variants (n=20) and 2) subjects with SCN1A mutations plus CACNA1A variants (n=20). CACNA1A variants detected in patients were studied using heterologous expression of recombinant human Cav2.1 in HEK 293 cells and whole-cell patch-clamp recording.Nine CACNA1A variants, including six novel ones, were detected in 21 of the 48 subjects (43.8%). Based on the incidence of variants in healthy controls, most of the variants seemed to be common polymorphisms. However, the subjects harboring SCN1A mutations and CACNA1A variants had absence seizures more frequently than the patients with only SCN1A mutations (8/20 vs. 0/20, p=0.002). Moreover, the former group of subjects exhibited earlier onset of seizures and more frequent prolonged seizures before one year of age, compared to the latter group of subjects. The electrophysiological properties of four of the five novel Cav2.1 variants exhibited biophysical changes consistent with gain-of-function. We conclude that CACNA1A variants in some persons with Dravet syndrome may modify the epileptic phenotypes.

KW - CACNA1A

KW - Electrophysiology

KW - Epilepsy

KW - Molecular genetics

KW - SCN1A

UR - http://www.scopus.com/inward/record.url?scp=84870192590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870192590&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2012.10.016

DO - 10.1016/j.nbd.2012.10.016

M3 - Article

C2 - 23103419

AN - SCOPUS:84870192590

VL - 50

SP - 209

EP - 217

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 1

ER -